MSB 2.08% 94.0¢ mesoblast limited

Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD, page-524

  1. 16,944 Posts.
    lightbulb Created with Sketch. 2409
    "Jb1975 is there a better alternative to treat paediatric SR aGvHD than Remestemcel-l "

    Well so far it hasn't been convincingly demonstrated to be any more efficacious than using Medicinal Compound (Lily The Pink Inc)

    Until the FDA have received a successful RCT that improves on the previous two trials by Osiris, that's still the most likely verdict.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.